Upregulation of toll-like receptor 4 on T cells in PBMCs is associated with disease aggravation of HBV-related acute-on-chronic liver failure

Abstract

Immune-mediated inflammatory injury is an important feature of the disease aggravation of hepatitis B virus-related acute-on-chronic liver failure (ACLF). Toll-like receptors (TLRs) have been shown previously to play a pivotal role in the activation of innate immunity. The purpose of this study was to characterize the TLR4 expression in peripheral blood mononuclear cells (PBMCs) of ACLF patients and its possible role in the disease aggravation. Twelve healthy subjects, 15 chronic HBV-infected (CHB) patients and 15 ACLF patients were enrolled in this study. The TLR4 expression in PBMCs and T cells of all subjects was examined by real-time PCR and flow cytometry. The correlation of TLR4 expression on T cells with the markers of disease aggravation was evaluated in ACLF patients. The ability of TLR4 ligands stimulation to induce inflammatory cytokine production in ACLF patients was analyzed by flow cytometry. The results showed that TLR4 mRNA level was upregulated in PBMCs of ACLF patients compared to that in the healthy subjects and the CHB patients. Specifically, the expression of TLR4 on CD4⁺ and CD8⁺ T cells of PBMCs was significantly increased in ACLF patients. The TLR4 levels on CD4⁺ and CD8⁺ T cells were positively correlated with serum total bilirubin (TBIL), direct bilirubin (DBIL), international normalized ratio (INR) levels and white blood cells (WBCs), and negatively correlated with serum albumin (ALB) levels in the HBV-infected patients, indicating TLR4 pathway may play a role in the disease aggravation of ACLF. In vitro TLR4 ligand stimulation on PBMCs of ACLF patients induced a strong TNF-α production by CD4⁺ T cells, which was also positively correlated with the serum markers for liver injury severity. It was concluded that TLR4 expression is upregulated on T cells in PBMCs, which is associated with the aggravation of ACLF.

Keywords

toll-like receptor / chronic hepatitis B / hepatitis B-related acute-on-chronic liver failure / peripheral blood mononuclear cells

References

[1] GanemD, PrinceAM. Hepatitis B virus infection—natural history and clinical consequences. N Engl J Med, 2004, 350(11): 1118-1129 PMID: 15014185

[2] ZhouJ, HuangY, TianD, et al. . Expression of toll-like receptor 9 in peripheral blood mononuclear cells from patients with different hepatitis B and C viral loads. J Huazhong Univ Sci Technolog Med Sci, 2009, 29(3): 313-317 PMID: 19513613

[3] NeubergerJ. Prediction of survival for patients with fulminant hepatic failure. Hepatology, 2005, 41(1): 19-22 PMID: 15690476

[4] SarinSK, KumarA, AlmeidaJA, et al. . Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int, 2009, 3(1): 269-282 PMCID: 2712314 PMID: 19669378

[5] SetoW L C, YuenMF. Acute-on-chronic liver failure in chronic hepatitis B. J Gastroenterol Hepatol, 2012, 27(4): 662-669 PMID: 22098452

[6] KimTY, KimDJ. Acute-on-chronic liver failure. Clin Mol Hepatol, 2013, 19(4): 349-359 PMCID: 3894433 PMID: 24459638

[7] KawaiT, AkiraS. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol, 2010, 11(5): 373-384 PMID: 20404851

[8] AkiraS, TakedaK. Toll-like receptor signalling. Nat Rev Immunol, 2004, 4(7): 499-511 PMID: 15229469

[9] ZhangE, LuM. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection. Med Microbiol Immunol, 2015, 204(1): 11-20 PMCID: 4305100 PMID: 25550115

[10] WangK, LiuH, HeY, et al. . Correlation of TLR1-10 expression in peripheral blood mononuclear cells with chronic hepatitis B and chronic hepatitis B-related liver failure. Hum Immunol, 2010, 71(10): 950-956 PMID: 20667457

[11] XingT, LiL, CaoH, et al. . Altered immune function of monocytes in different stages of patients with acute on chronic liver failure. ClinExp Immunol, 2007, 147(1): 184-188

[12] The guideline of preventiontreatment for chronic hepatitis B 2010 version.. Zhonghua Liu Xing Bing Xue Za Zhi (Chinese), 2011, 32(4): 405-415

[13] Zare-BidakiM, Tsukiyama-KoharaK, ArababadiMK. Toll-like receptor 4 and hepatitis B infection: molecular mechanisms and pathogenesis. Viral Immunol, 2014, 27(7): 321-326 PMID: 25014492

[14] ZhangE, LuM. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection. Med Microbiol Immunol, 2015, 204(1): 11-20 PMCID: 4305100 PMID: 25550115

[15] ChenZ, ChengY, XuY, et al. . Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients. Clin Immunol, 2008, 128(3): 400-408 PMID: 18565796

[16] ZhouY, ZhuN, WangX, et al. . The role of the toll-like receptor TLR4 in hepatitis B virus-associated glomerulonephritis. Arch Virol, 2013, 158(2): 425-433 PMID: 23076739

[17] SoaresJB, Pimentel-NunesP, AfonsoL, et al. . Increased hepatic expression of TLR2 and TLR4 in the hepatic inflammation-fibrosis-carcinoma sequence. Innate Immun, 2012, 18(5): 700-708 PMID: 22330637

[18] XingT, LiL, CaoH, et al. . Altered immune function of monocytes in different stages of patients with acute on chronic liver failure. Clin Exp Immunol, 2007, 147(1): 184-188 PMCID: 1810435 PMID: 17177978

[19] ElsingC, HarenbergS, StremmelW, et al. . Serum levels of soluble Fas, nitric oxide and cytokines in acute decompensated cirrhotic patients. World J Gastroenterol, 2007, 13(3): 421-425 PMCID: 4065898 PMID: 17230612

[20] PanC, GuY, ZhangW, et al. . Dynamic changes of lipopolysaccharide levels in different phases of acute on chronic hepatitis B liver failure. PLoS One, 2012, 7(11): 49460